Yamamoto Hideyuki

  • 24 Citations
  • 2 h-Index
20162020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Hideyuki Yamamoto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 24 Citations
  • 2 h-Index
  • 5 Article
  • 9 Citations (Scopus)

    Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD

    Kato, H., Yamamoto, K., Kodaira, T., Higuchi, Y., Yamamoto, H., Saito, T., Taji, H., Yatabe, Y., Nakamura, S. & Kinoshita, T., 07-02-2018, In : Hematology. 23, 2, p. 83-88 6 p.

    Research output: Contribution to journalArticle

    Open Access
  • Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma

    Kato, H., Yamamoto, K., Higuchi, Y., Yamamoto, H., Saito, T., Taji, H., Yatabe, Y., Nakamura, S. & Kinoshita, T., 01-12-2016, In : Chemotherapy. 62, 1, p. 19-22 4 p.

    Research output: Contribution to journalArticle

  • Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy

    Murakami, S., Kato, H., Higuchi, Y., Yamamoto, K., Yamamoto, H., Saito, T., Taji, H., Yatabe, Y., Nakamura, S. & Kinoshita, T., 01-08-2016, In : Annals of Hematology. 95, 8, p. 1259-1269 11 p.

    Research output: Contribution to journalArticle

  • 6 Citations (Scopus)